Sequoia Capital China, widely viewed as a bellwether for Chinese tech investments, has reportedly launched a new fund that focuses on investing in publicly listed health and biotech companies.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
